Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Philip Poorvu, M.D.

Concepts (125)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms252023208271.150 Why?
Pregnancy Complications, Neoplastic220212550.810 Why?
Gonadotropin-Releasing Hormone2201812050.740 Why?
Fertility220217790.560 Why?
Ovariectomy120186610.530 Why?
Uterine Hemorrhage120152550.470 Why?
Ovary120189800.450 Why?
Amenorrhea120154850.410 Why?
Organs at Risk120123460.370 Why?
Radiation Injuries2201311800.320 Why?
Receptor, erbB-25202324180.320 Why?
BRCA2 Protein320237940.310 Why?
BRCA1 Protein4202311480.310 Why?
Radiotherapy, Intensity-Modulated220138060.290 Why?
Endometrial Neoplasms2201313500.280 Why?
Preoperative Care1201522510.280 Why?
Gastrointestinal Tract120128140.280 Why?
Neoplasm Recurrence, Local4202192390.240 Why?
Neoadjuvant Therapy4202327270.220 Why?
Receptors, Estrogen3202021900.210 Why?
Lymphatic Metastasis2202129240.210 Why?
Pregnancy Rate220206430.190 Why?
Quality of Life32021127880.190 Why?
Uterine Cervical Neoplasms1201220180.180 Why?
Live Birth220205120.180 Why?
Antineoplastic Combined Chemotherapy Protocols32023115240.170 Why?
Hematopoietic Stem Cell Transplantation1201554450.150 Why?
Estrogen Receptor alpha120215770.150 Why?
Receptors, Progesterone1202110980.140 Why?
Chemotherapy, Adjuvant3202234800.140 Why?
Age Factors52021183550.140 Why?
Female2820233800200.140 Why?
Prospective Studies102023532500.140 Why?
Germ-Line Mutation2202317870.140 Why?
Antineoplastic Agents, Hormonal2202215230.130 Why?
Mastectomy2202017930.130 Why?
Goserelin120151290.130 Why?
Confidence Intervals1202029710.120 Why?
Age Distribution1202028990.120 Why?
Adult1920222138890.120 Why?
Contraceptive Agents, Female120151350.120 Why?
Leuprolide120153210.120 Why?
Pregnancy Outcome2202127940.120 Why?
Tamoxifen120189810.110 Why?
Young Adult72022563920.110 Why?
Carcinoma, Ductal, Breast1202011000.110 Why?
Lymphatic Irradiation120121030.110 Why?
Humans2920237438110.100 Why?
Adaptation, Psychological1202225750.100 Why?
Guidelines as Topic1201814040.100 Why?
Dose-Response Relationship, Radiation120128760.100 Why?
Anxiety2202242880.090 Why?
Radiation-Sensitizing Agents120123580.090 Why?
Adolescent62022857290.090 Why?
Duodenum120124840.090 Why?
Pregnancy52021291400.080 Why?
Lymph Nodes1201934760.080 Why?
Odds Ratio1202098480.080 Why?
Genetic Testing1202134390.080 Why?
Germ Cells220226290.080 Why?
Survivors3202222910.070 Why?
Neoplasm Metastasis1201848480.070 Why?
Decision Support Techniques1201719560.070 Why?
Cisplatin1201216620.070 Why?
Combined Modality Therapy2202286370.070 Why?
Intestine, Small1201212400.070 Why?
Retrospective Studies82021774100.070 Why?
Multivariate Analysis12019122430.070 Why?
Aorta1201220620.060 Why?
Central Nervous System Neoplasms120138950.060 Why?
Colon1201217720.060 Why?
Analysis of Variance1201263560.060 Why?
Time Factors32020400380.060 Why?
Gene Expression Profiling1201994400.060 Why?
Decision Making1201738870.060 Why?
Prognosis22021290520.050 Why?
Treatment Outcome32020630420.050 Why?
Aged, 80 and over32018577440.050 Why?
Phthalazines120233590.050 Why?
Cohort Studies22020405450.050 Why?
Medicare1201865650.040 Why?
Genetic Predisposition to Disease12021174390.040 Why?
Aged520221631780.040 Why?
Class I Phosphatidylinositol 3-Kinases120228900.040 Why?
Antineoplastic Agents12021136910.040 Why?
Adjuvants, Immunologic120229990.040 Why?
Reproductive Techniques, Assisted120214820.040 Why?
Mutation12021297770.040 Why?
Disease-Free Survival2202068950.040 Why?
Paclitaxel1202317050.030 Why?
Body Image120206100.030 Why?
Life Expectancy1202211840.030 Why?
Mastectomy, Segmental120209560.030 Why?
Congenital Abnormalities120207070.030 Why?
Continuity of Patient Care1202110490.030 Why?
Child32021776370.030 Why?
Fatigue1202115300.030 Why?
Fear1202114380.030 Why?
Middle Aged520222132410.030 Why?
Social Support1202221180.030 Why?
Anorexia120131610.030 Why?
Weight Gain1202222940.030 Why?
Body Weight1202246700.020 Why?
Mammography1202224750.020 Why?
Weight Loss1202226250.020 Why?
Nausea120136740.020 Why?
United States12018698590.020 Why?
Vomiting120136360.020 Why?
Alopecia120133820.020 Why?
Internet1202130580.020 Why?
Neoplasm Staging12022110360.020 Why?
Radiotherapy Dosage1201328790.020 Why?
Pregnancy Complications1202028610.020 Why?
Genomics1202257140.020 Why?
Headache1201312240.020 Why?
Predictive Value of Tests12021150670.020 Why?
Sleep Initiation and Maintenance Disorders1201310040.010 Why?
Risk Factors22021722520.010 Why?
Kaplan-Meier Estimate1201365390.010 Why?
Depression1202077600.010 Why?
Risk Assessment12020233270.010 Why?
Positron-Emission Tomography1201362370.010 Why?
Infant12013351220.010 Why?
Child, Preschool12013409640.010 Why?
Male120133497760.000 Why?
Poorvu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (125)
Explore
_
Co-Authors (44)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.